51
|
Osborn EA, Kessinger CW, Tawakol A, Jaffer FA. Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism. J Nucl Med 2017; 58:871-877. [PMID: 28450558 DOI: 10.2967/jnumed.116.182873] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Accepted: 04/19/2017] [Indexed: 12/27/2022] Open
Abstract
Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment.
Collapse
Affiliation(s)
- Eric A Osborn
- Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and.,Cardiology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
| | - Chase W Kessinger
- Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and
| | - Ahmed Tawakol
- Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and
| | - Farouc A Jaffer
- Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and
| |
Collapse
|
52
|
Toutouzas K, Benetos G, Koutagiar I, Barampoutis N, Mitropoulou F, Davlouros P, Sfikakis PP, Alexopoulos D, Stefanadis C, Siores E, Tousoulis D. Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study. Atherosclerosis 2017; 262:25-30. [PMID: 28482222 DOI: 10.1016/j.atherosclerosis.2017.04.019] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2017] [Revised: 04/19/2017] [Accepted: 04/21/2017] [Indexed: 11/30/2022]
Abstract
BACKGROUND AND AIMS Limited prospective data have been reported regarding the impact of carotid inflammation on cardiovascular events in patients with coronary artery disease (CAD). Microwave radiometry (MWR) is a noninvasive, simple method that has been used for evaluation of carotid artery temperature which, when increased, predicts 'inflamed' plaques with vulnerable characteristics. We prospectively tested the hypothesis that increased carotid artery temperature predicts future cerebro- and cardiovascular events in patients with CAD. METHODS Consecutive patients from 3 centers, with documented CAD by coronary angiography, were studied. In both carotid arteries, common carotid intima-media thickness and plaque thickness were evaluated by ultrasound. Temperature difference (ΔT), measured by MWR, was considered as the maximal temperature along the carotid artery minus the minimum; ΔT ≥0.90 °C was assigned as high. Major cardiovascular events (MACE, death, stroke, myocardial infarction or revascularization) were recorded during the following year. RESULTS In total, 250 patients were studied; of them 40 patients (16%) had high ΔT values in both carotid arteries. MACEs occurred in 30% of patients having bilateral high ΔT versus 3.8% in the remaining patients (p<0.001). Bilateral high ΔT was independently associated with increased one-year MACE rate (HR = 6.32, 95% CI 2.42-16.53, p<0.001, by multivariate cox regression hazard model). The addition of ΔT information on a baseline model based on cardiovascular risk factors and extent of CAD significantly increased the prognostic value of the model (c-statistic increase 0.744 to 0.845, pdif = 0.05) CONCLUSIONS: Carotid inflammation, detected by MWR, has an incremental prognostic value in patients with documented CAD.
Collapse
Affiliation(s)
- Konstantinos Toutouzas
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece.
| | - Georgios Benetos
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece
| | - Iosif Koutagiar
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece
| | | | - Fotini Mitropoulou
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece
| | | | - Petros P Sfikakis
- First Department of Propedeutic and Internal Medicine, National & Kapodistrian University Medical School, Athens, Greece
| | - Dimitrios Alexopoulos
- Cardiology Department, University Hospital of Patras, Patras, Greece; Second Department of Cardiology, Attiko Hospital, National & Kapodistrian University Medical School, Athens, Greece
| | - Christodoulos Stefanadis
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece
| | - Elias Siores
- Centre for Materials, Research and Innovation, University of Bolton, Bolton, UK
| | - Dimitris Tousoulis
- First Department of Cardiology, Hippokration Hospital, National & Kapodistrian University Medical School, Athens, Greece
| |
Collapse
|
53
|
Affiliation(s)
- Marc R Dweck
- From the Translation Molecular Imaging Institute, Icahn School of Medicine at Mount-Sinai, New York (M.R.D.); British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom (M.R.D.); and Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Inserm 1148, Paris, France (F.H.).
| | - Fabien Hyafil
- From the Translation Molecular Imaging Institute, Icahn School of Medicine at Mount-Sinai, New York (M.R.D.); British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom (M.R.D.); and Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Inserm 1148, Paris, France (F.H.)
| |
Collapse
|